Table 2.
Subgroup analysis of HGS.
| Subtotal (n) | Number of studies (n) | WMD (95% CI) | P-value | |
|---|---|---|---|---|
| Age | ||||
| >50 | 2,736 | 4 | 1.353 (−0.238; 2.944) | 0.096 |
| >60 | 870 | 4 | 1.116 (0.433; 1.799) | 0.001 |
| >70 | 623 | 2 | −0.379 (−0.944; 0.186) | 0.189 |
| With calcium or not | ||||
| with calcium | 3,816 | 6 | 0.478 (−0.165; 1.122) | 0.145 |
| without calcium | 413 | 4 | 1.931 (0.166; 3.697) | 0.032 |
| Baseline serum vitamin D level | ||||
| <30 ng/ml | 1,125 | 6 | 1.445 (0.486; 2.403) | 0.527 |
| >30 ng/ml | 757 | 3 | 0.478 (−0.963; 1.918) | 0.003 |
| Vitamin D dosage (IU/day) | ||||
| <1,000 | 2,769 | 3 | 0.206 (−0.218; 0.630) | 0.341 |
| ≥1,000 | 847 | 3 | 0.161 (−0.911; 1.234) | 0.768 |
| vitamin D analogs | 613 | 4 | 2.118 (1.024; 3.213) | 0 |
| Supplementation duration | ||||
| >12 | 3,059 | 3 | 0.621 (−0.219; 1.461) | 0.147 |
| <12 | 1,170 | 7 | 1.193 (−0.090; 2.477) | 0.068 |
WMD, weighted mean difference; CI, confidence interval.